Nutrition and Exercise for Sarcopenia
Primary Purpose
Sarcopenia
Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Amino acids
Exercise
Sponsored by
About this trial
This is an interventional prevention trial for Sarcopenia focused on measuring Sarcopenia, nutrition, aging, metabolism, exercise
Eligibility Criteria
Inclusion Criteria:
- age 65-85 yrs
- ability to sign consent form (score >25 on the 30 item Mini Mental State Examination, MMSE)
- stable body weight for at least 1 year (verified via medical records).
Exclusion Criteria:
- physical dependence or frailty (impairment in any of the Activities of Daily Living (ADL), history of falls (≥2/year) or significant weight loss in the past year)
- exercise training (≥2 weekly sessions of moderate-to-high intensity aerobic or resistance exercise)
- significant heart, liver, kidney, blood or respiratory disease
- peripheral vascular disease
- diabetes or other untreated endocrine disease
- active cancer
- recent (within 6 months) treatment with anabolic steroids, or corticosteroids
- alcohol or drug abuse
- tobacco use (smoking or chewing, verified via medical records)
- depression (>5 on the 15-item Geriatric Depression Scale (GDS))
- malnutrition (BMI <20 kg/m2; hypoalbuminemia or hypotransferrenemia; protein intake<0.66 g/kg/day at run-in)
- obesity (BMI>30 kg/m2).
Sites / Locations
- Sealy Center on Aging, University of Texas Medical Branch
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Experimental
No Intervention
Arm Label
Nutritional supplement
Placebo + Exercise
Nutritional Supplement + Exercise
Placebo
Arm Description
Outcomes
Primary Outcome Measures
Muscle mass
Secondary Outcome Measures
Muscle function
muscle protein turnover
Full Information
NCT ID
NCT00872911
First Posted
March 27, 2009
Last Updated
December 8, 2016
Sponsor
The University of Texas Medical Branch, Galveston
Collaborators
National Institute on Aging (NIA)
1. Study Identification
Unique Protocol Identification Number
NCT00872911
Brief Title
Nutrition and Exercise for Sarcopenia
Official Title
Nutrition and Exercise to Improve Protein Metabolism and Prevent Sarcopenia in Aging
Study Type
Interventional
2. Study Status
Record Verification Date
December 2016
Overall Recruitment Status
Completed
Study Start Date
March 2009 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
August 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The University of Texas Medical Branch, Galveston
Collaborators
National Institute on Aging (NIA)
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The investigators' general hypothesis is that nutritional factors, including protein/energy malnutrition and/or an impaired response of muscle to nutrition, and inactivity play significant roles in developing sarcopenia, the involuntary loss of muscle mass and function with age. Therefore, age-specific prolonged interventions including nutritional manipulations and/or exercise may help to reduce, stabilize, or even reverse sarcopenia.
Detailed Description
Our preliminary studies indicate that, in older adults, muscle protein anabolism is normally stimulated by amino acids alone, but impaired when nutritional stimuli contain carbohydrate due to a relative insulin resistance of muscle protein synthesis. We have also found that amino acids are the most efficient nutrients for the acute stimulation of muscle protein anabolism and our pilot data suggest that they can also increase muscle mass in healthy older adults.
Inactivity is another likely contributor to sarcopenia. Exercise increases not only muscle protein synthesis,mass and strength, but also energy expenditure. Hence, exercise may improve the response of muscle to nutritional interventions in older subjects via increased energy requirements and food consumption, thereby allowing for achievement of true supplementation.
We will test the following specific hypotheses in older, community indwelling, sedentary subjects:
Using a factorial design we will address in older, community-indwelling, sedentary subjects the following hypotheses:
Nutritional supplementation with amino acids will improve muscle mass, strength, function, quality, and protein synthesis.
Progressive exercise training for 24 weeks will improve muscle mass strength,function, quality, perfusion, and protein metabolism.
Combined treatment with nutritional supplementation and progressive exercise training for 24 weeks will improve muscle mass, strength, function, quality, perfusion, and protein metabolism more than either intervention alone.
Our goal is to establish if specific interventions that can acutely increase muscle protein synthesis can also effectively translate into increased muscle mass and/or performance in older sedentary people, thus preventing frailty and promoting physical independence. To this end we will use stable isotope methodologies to measure muscle protein metabolism and contrast enhanced ultrasound to measure muscle perfusion, in order to determine if the treatments' acute effects can predict their chronic impact on muscle mass and function. We will also determine if chronic treatment leads to metabolic and/or vascular adaptations that may explain the measured changes in muscle mass and function.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sarcopenia
Keywords
Sarcopenia, nutrition, aging, metabolism, exercise
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 1
Interventional Study Model
Factorial Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
108 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Nutritional supplement
Arm Type
Experimental
Arm Title
Placebo + Exercise
Arm Type
Experimental
Arm Title
Nutritional Supplement + Exercise
Arm Type
Experimental
Arm Title
Placebo
Arm Type
No Intervention
Intervention Type
Dietary Supplement
Intervention Name(s)
Amino acids
Intervention Description
mixed pure crystalline amino acids for human use (Ajinomoto), 15 g/d
Intervention Type
Drug
Intervention Name(s)
Exercise
Intervention Description
progressive exercise training
Primary Outcome Measure Information:
Title
Muscle mass
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Muscle function
Time Frame
6 months
Title
muscle protein turnover
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
age 65-85 yrs
ability to sign consent form (score >25 on the 30 item Mini Mental State Examination, MMSE)
stable body weight for at least 1 year (verified via medical records).
Exclusion Criteria:
physical dependence or frailty (impairment in any of the Activities of Daily Living (ADL), history of falls (≥2/year) or significant weight loss in the past year)
exercise training (≥2 weekly sessions of moderate-to-high intensity aerobic or resistance exercise)
significant heart, liver, kidney, blood or respiratory disease
peripheral vascular disease
diabetes or other untreated endocrine disease
active cancer
recent (within 6 months) treatment with anabolic steroids, or corticosteroids
alcohol or drug abuse
tobacco use (smoking or chewing, verified via medical records)
depression (>5 on the 15-item Geriatric Depression Scale (GDS))
malnutrition (BMI <20 kg/m2; hypoalbuminemia or hypotransferrenemia; protein intake<0.66 g/kg/day at run-in)
obesity (BMI>30 kg/m2).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elena Volpi, MD,PhD
Organizational Affiliation
The University of Texas Medical Branch, Galveston
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sealy Center on Aging, University of Texas Medical Branch
City
Galveston
State/Province
Texas
ZIP/Postal Code
77550
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
31307843
Citation
Randolph AC, Markofski MM, Rasmussen BB, Volpi E. Effect of essential amino acid supplementation and aerobic exercise on insulin sensitivity in healthy older adults: A randomized clinical trial. Clin Nutr. 2020 May;39(5):1371-1378. doi: 10.1016/j.clnu.2019.06.017. Epub 2019 Jun 28.
Results Reference
derived
PubMed Identifier
29750251
Citation
Markofski MM, Jennings K, Timmerman KL, Dickinson JM, Fry CS, Borack MS, Reidy PT, Deer RR, Randolph A, Rasmussen BB, Volpi E. Effect of Aerobic Exercise Training and Essential Amino Acid Supplementation for 24 Weeks on Physical Function, Body Composition, and Muscle Metabolism in Healthy, Independent Older Adults: A Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci. 2019 Sep 15;74(10):1598-1604. doi: 10.1093/gerona/gly109.
Results Reference
derived
Learn more about this trial
Nutrition and Exercise for Sarcopenia
We'll reach out to this number within 24 hrs